Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Steroids. 2010 Jan 25;75(11):772–778. doi: 10.1016/j.steroids.2010.01.011

TABLE 6.

Cox regression models for progression in renal status: A) from normal AER to microalbuminuria, B) from microalbuminuria to macroalbuminuria, and C) from macroalbuminuria to end-stage renal disease (ESRD).

Model A
Variable Hazard ratio (95%CI) P-value
Duration of diabetes (yrs) 0.97 (0.93 – 1.02) 0.213
WHR 557.96 (1.65 – 188561.26) 0.033
HbA1c (%) 1.37 (1.09 – 1.72) 0.008
ln(Triglycerides) 0.95 (0.61 – 1.71) 0.982
eGDR (mg/kg/min) 1.15 (0.92 – 1.44) 0.214
ln(cFt) 0.89 (0.41 – 1.96) 0.776
ln(cFe) 1.01 (0.68 – 1.49) 0.945
SHBG (nmol/l) 1.00 (0.99 – 1.01) 0.666
Model B
Variable Hazard ratio (95%CI) P-value
Systolic blood pressure (mmHg) 1.02 (1.00 – 1.05) 0.096
WHR 0.04 (0.01 – 726.67) 0.529
HbA1c (%) 1.17 (0.91 – 1.51) 0.230
ln(Triglycerides) 3.44 (1.48 – 8.04) 0.004
eGDR (mg/kg/min) 0.93 (0.65 – 1.33) 0.690
ln(cFt) 0.43 (0.19 – 0.95) 0.036
ln(cFe) 1.18 (0.77 – 1.81) 0.445
SHBG (nmol/l) 1.00 (0.99 – 1.01) 0.822
Model C
Variable Hazard ratio (95%CI) P-value
ln(cFe) 3.03 (1.67 – 5.50) <0.001
eGFR (ml/min/1.73m2) 0.95 (0.93 – 0.97) <0.001
ln(cFt) 0.46 (0.22 – 0.96) 0.038
ln(Triglycerides) 1.68 (0.93 – 3.02) 0.085
SHBG (nmol/l) 1.01 (1.00 – 1.01) 0.221